Cognitive and Neurologic Rehabilitation Strategies for Central Nervous System HIV Infection.


Journal

Current HIV/AIDS reports
ISSN: 1548-3576
Titre abrégé: Curr HIV/AIDS Rep
Pays: United States
ID NLM: 101235661

Informations de publication

Date de publication:
10 2020
Historique:
pubmed: 28 8 2020
medline: 17 2 2021
entrez: 27 8 2020
Statut: ppublish

Résumé

Cognitive impairment leading to disability is increasingly seen in people living with human immunodeficiency virus (PLWH). Rehabilitation can alleviate the effects of cognitive impairment upon function. The aim of this paper is to discuss the strategies that have been used in cognitive and neurologic rehabilitation in PLWH. Studies examining pharmacological and non-pharmacological strategies were analysed. Medical management of HIV and co-morbidities should be optimised. Non-pharmacological strategies, including nerve stimulation techniques, exercise-based interventions, and paper and computer-based cognitive rehabilitation, have some evidence supporting their use in PLWH either as stand-alone interventions or as part of a multidisciplinary approach. Both pharmacological and non-pharmacological rehabilitation strategies have been used with PLWH. More intervention trials are needed to assess cognitive and neurological rehabilitation strategies and further evaluate their potential benefit in PLWH.

Identifiants

pubmed: 32844275
doi: 10.1007/s11904-020-00515-0
pii: 10.1007/s11904-020-00515-0
pmc: PMC7497368
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

514-521

Références

Open Forum Infect Dis. 2019 Jul 08;6(7):ofz277
pubmed: 31304188
HIV Med. 2014 Jan;15 Suppl 1:1-85
pubmed: 24330011
J Neurovirol. 2018 Oct;24(5):557-569
pubmed: 29785584
Hepatology. 2002 Feb;35(2):433-9
pubmed: 11826420
J Acquir Immune Defic Syndr. 2019 Jan 1;80(1):e14-e22
pubmed: 30272630
Disabil Rehabil. 2012;34(22):1871-9
pubmed: 22506959
Disabil Rehabil. 2009;31(10):825-30
pubmed: 19037776
Neurosci Biobehav Rev. 2013 Nov;37(9 Pt B):2243-57
pubmed: 23623982
AIDS. 2014 May 15;28(8):1193-202
pubmed: 24556869
Arch Neurol. 2008 Jan;65(1):65-70
pubmed: 18195140
J Neurovirol. 2012 Oct;18(5):388-99
pubmed: 22811264
J Neurovirol. 2011 Feb;17(1):3-16
pubmed: 21174240
AIDS Res Hum Retroviruses. 2016 Aug;32(8):743-55
pubmed: 27045714
HIV Med. 2007 Nov;8(8):520-8
pubmed: 17944685
AIDS. 2009 Jul 17;23(11):1359-66
pubmed: 19424052
Neurology. 2013 Feb 5;80(6):553-60
pubmed: 23345635
N Engl J Med. 2015 Aug 27;373(9):795-807
pubmed: 26192873
J Neuroimmune Pharmacol. 2007 Mar;2(1):120-7
pubmed: 18040835
AIDS. 2012 Sep 10;26(14):1765-74
pubmed: 22614889
AIDS. 2006 Sep 11;20(14):1885-8
pubmed: 16954730
AIDS. 2016 Feb 20;30(4):591-600
pubmed: 26825032
J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):174-82
pubmed: 17356465
AIDS. 2013 Jan 28;27(3):391-400
pubmed: 23079813
Ann Neurol. 1986 Jun;19(6):517-24
pubmed: 3729308
J Neurovirol. 2014 Dec;20(6):571-82
pubmed: 25227930
Clin Rehabil. 1999 Aug;13(4):277-87
pubmed: 10460115
AIDS. 1998 May 28;12(8):F65-70
pubmed: 9631133
Clin Neuropsychol. 2010 Feb;24(2):265-85
pubmed: 20162495
J Neurovirol. 2002 Apr;8(2):136-42
pubmed: 11935465
PLoS One. 2017 May 11;12(5):e0176686
pubmed: 28493892
AIDS. 2010 Jun 1;24(9):1243-50
pubmed: 19996937
J Neuroimmune Pharmacol. 2015 Sep;10(3):487-92
pubmed: 25900078
Neurology. 2008 Aug 12;71(7):521-4
pubmed: 18695163
Disabil Rehabil. 2012;34(21):1848-52
pubmed: 22458375
Antivir Ther. 2015;20(4):441-7
pubmed: 25516553
Neurology. 2011 Apr 19;76(16):1403-9
pubmed: 21502598
Clin Neuropsychol. 2016;30(1):107-30
pubmed: 26753986
Front Neurosci. 2016 Dec 27;10:584
pubmed: 28082858
J Addict Dis. 2008;27(2):11-7
pubmed: 18681187
Neurology. 2010 Dec 7;75(23):2087-96
pubmed: 21135382
Neurol Res. 2019 Nov;41(11):1001-1007
pubmed: 31588880
Clin Infect Dis. 2018 Sep 28;67(8):1182-1190
pubmed: 29617912
Int J Yoga. 2019 May-Aug;12(2):132-138
pubmed: 31143021
Neurology. 2010 Apr 20;74(16):1260-6
pubmed: 20237308
Eur J Neurol. 2011 Mar;18(3):527-34
pubmed: 21159073
Neurology. 2009 Aug 4;73(5):342-8
pubmed: 19474412
Front Behav Neurosci. 2015 Nov 16;9:306
pubmed: 26635558
AIDS Care. 2017 Jun;29(6):667-674
pubmed: 27892704
Hippocampus. 2006;16(12):1091-101
pubmed: 17024677
Transp Res Part F Traffic Psychol Behav. 2018 Oct;58:1061-1073
pubmed: 31354384
Neurology. 2011 Sep 20;77(12):1135-42
pubmed: 21900636
Appl Neuropsychol Adult. 2019 Jan-Feb;26(1):36-47
pubmed: 29020472
Eur J Neurol. 2005 Sep;12(9):665-80
pubmed: 16128867
Int J Palliat Nurs. 2000 Jan;6(1):6-11
pubmed: 12819563
Clin Infect Dis. 2013 Jul;57(1):101-8
pubmed: 23515205
Cochrane Database Syst Rev. 2019 Jan 14;1:CD012732
pubmed: 30637728
Clin Infect Dis. 2010 Mar 1;50(5):773-8
pubmed: 20100092

Auteurs

Terrence Chan (T)

Mildmay Hospital, 19 Tabernacle Gardens, London, E2 7DZ, UK.

Monica Marta (M)

Grahame Hayton Unit, I&I and Neurology Department, Barts Health NHS Trust, London, UK.
Neurosciences, Blizard Institute, Queen Mary University of London, London, UK.

Camilla Hawkins (C)

Mildmay Hospital, 19 Tabernacle Gardens, London, E2 7DZ, UK.

Simon Rackstraw (S)

Mildmay Hospital, 19 Tabernacle Gardens, London, E2 7DZ, UK. simon.rackstraw@mildmay.org.
Grahame Hayton Unit, I&I and Neurology Department, Barts Health NHS Trust, London, UK. simon.rackstraw@mildmay.org.
Neurosciences, Blizard Institute, Queen Mary University of London, London, UK. simon.rackstraw@mildmay.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH